Replies to post #5841 on Insmed Inc (INSM)

[DewDiligence]

>I wondered also if a FOB pathway could be found without major legislation, maybe some current rule tweaking.<

It already has been found—e.g. Omnitrope from NVS (#msg-11358021). But this kind of FoB approval (via the 505b2 pathway) will work only for the simplest kinds of protein drugs. Regards, Dew